IRIS
SCIONTI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.588
AS - Asia 1.148
EU - Europa 869
SA - Sud America 175
AF - Africa 57
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3.848
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.510
SG - Singapore 455
IT - Italia 431
CN - Cina 205
IN - India 129
BR - Brasile 128
GB - Regno Unito 102
DE - Germania 99
VN - Vietnam 89
FI - Finlandia 52
CA - Canada 47
HK - Hong Kong 46
BD - Bangladesh 41
SE - Svezia 34
NL - Olanda 31
PK - Pakistan 29
ID - Indonesia 26
JO - Giordania 24
MX - Messico 21
SA - Arabia Saudita 18
ES - Italia 17
FR - Francia 16
RU - Federazione Russa 16
ZA - Sudafrica 15
CZ - Repubblica Ceca 12
EG - Egitto 12
IQ - Iraq 12
CO - Colombia 11
TR - Turchia 11
UA - Ucraina 10
MY - Malesia 9
LT - Lituania 8
NG - Nigeria 8
PE - Perù 8
AE - Emirati Arabi Uniti 7
AR - Argentina 7
AU - Australia 7
IE - Irlanda 7
IR - Iran 7
KE - Kenya 7
PT - Portogallo 7
VE - Venezuela 7
ET - Etiopia 6
LB - Libano 6
RO - Romania 6
EC - Ecuador 5
MA - Marocco 5
AL - Albania 4
CY - Cipro 4
JP - Giappone 4
PH - Filippine 4
BG - Bulgaria 3
CL - Cile 3
GT - Guatemala 3
HN - Honduras 3
HR - Croazia 3
KR - Corea 3
PS - Palestinian Territory 3
PY - Paraguay 3
TH - Thailandia 3
UZ - Uzbekistan 3
AT - Austria 2
AZ - Azerbaigian 2
CH - Svizzera 2
EU - Europa 2
IL - Israele 2
KZ - Kazakistan 2
LK - Sri Lanka 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BO - Bolivia 1
BY - Bielorussia 1
CD - Congo 1
CM - Camerun 1
EE - Estonia 1
GE - Georgia 1
HU - Ungheria 1
JM - Giamaica 1
MD - Moldavia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PL - Polonia 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 3.848
Salva come PNG Salva come JPEG
Città #
San Jose 301
Singapore 211
Ashburn 174
Chandler 161
Dallas 89
Santa Clara 74
Munich 72
Bengaluru 57
Hefei 57
Chicago 56
London 51
Milan 45
Beijing 40
Ho Chi Minh City 40
Hong Kong 36
Turku 35
Lawrence 34
Princeton 34
Catanzaro 33
Los Angeles 28
New York 25
Boardman 19
Ottawa 19
Helsinki 17
Amman 16
Hanoi 16
Wilmington 15
Rome 14
Jeddah 13
São Paulo 13
Carbonia 12
San Nicola Manfredi 12
Atlanta 10
Chennai 10
Montreal 10
Naples 10
San Francisco 10
Spezzano della Sila 10
The Dalles 10
Brooklyn 9
Madrid 9
Bologna 8
Delhi 8
Irbid 8
Manchester 8
Olomouc 8
Palermo 8
Catania 7
Cosenza 7
Council Bluffs 7
Da Nang 7
Kaunas 7
Aversa 6
Bari 6
Des Moines 6
Ercolano 6
Frankfurt am Main 6
Hyderabad 6
Nairobi 6
Redmond 6
Seattle 6
Addis Ababa 5
Afragola 5
Ahmedabad 5
Buffalo 5
Cardiff 5
Dhaka 5
Islamabad 5
Johannesburg 5
Kuala Lumpur 5
Kyiv 5
Lahore 5
Lucknow 5
Meppel 5
Mexico City 5
Orem 5
Pune 5
Riyadh 5
Sacramento 5
Santo Stefano di Rogliano 5
Stockholm 5
Ankara 4
Brescia 4
Cape Town 4
Charlotte 4
Dublin 4
Florianópolis 4
Haiphong 4
Istanbul 4
Lima 4
Melbourne 4
Nicosia 4
Paris 4
Phoenix 4
Tanta 4
Toronto 4
Tubarão 4
Acquaviva delle Fonti 3
Ajman 3
Amsterdam 3
Totale 2.217
Salva come PNG Salva come JPEG
Nome #
Pharmacogenetics/Pharmacogenomics of Drug-Metabolizing Enzymes and Transporters 487
A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells 142
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 117
miR-22 suppresses DNA ligase III addiction in multiple myeloma 103
Identification of ADME genes polymorphic variants linked to trastuzumab-induced cardiotoxicity in breast cancer patients: Case series of mono-institutional experience 100
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review 94
A 46,XY Female with a 9p24.3p24.1 Deletion and a 8q24.11q24.3 Duplication: A Case Report and Review of the Literature. 81
Identification of polymorphic variants associated with erlotinib-related skin toxicity in advanced non-small cell lung cancer patients by DMET microarray analysis 79
Raman Spectroscopic Stratification of Multiple Myeloma Patients Based on Exosome Profiling 79
A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and Pharmacogenomics 78
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 76
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia 75
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma. (CO-FIRST AUTHOR) 75
Identifying prognostic markers for multiple myeloma through integration and analysis of MMRF-CoMMpass data 75
Discovery, Functional Characterization and Therapeutic Targeting of Lnc-17-92 Metabolic Signaling in Multiple Myeloma 73
Non-coding RNAs in cancer: Platforms and strategies for investigating the genomic "dark matter" 73
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin 71
DmetTM genotyping: Tools for biomarkers discovery in the era of precision medicine 70
Allometric scaling approaches for predicting human pharmacokinetic of a locked nucleic acid oligonucleotide targeting cancer-associated miR-221 68
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma 66
Chromene Derivatives as Selective TERRA G-Quadruplex RNA Binders with Antiproliferative Properties 65
Polymorphic variants in NR1I3 and UGT2B7 predict taxane neurotoxicity and have prognostic relevance in breast cancer patients: a case-control study. 65
Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma 64
Anti-MALAT1 synthetic oligonucleotides target the proteasome and exert anti-multiple myeloma activity 61
From single level analysis to multi-omics integrative approaches: A powerful strategy towards the precision oncology 61
Modeling UGT2B7 and NR1I3 genes through multilayer network to highlight hidden link with taxane neurotoxicity 59
A MIR17HG-derived Long Noncoding RNA Provides an Essential Chromatin Scaffold for Protein Interaction and Myeloma Growth 59
Pharmacogenomics biomarker discovery and validation for translation in clinical practice. 59
Pharmacogenomic Profiling of ADME Gene Variants: Current Challenges and Validation Perspectives 58
Mir-22 modulates lenalidomide activity by counteracting myc addiction in multiple myeloma 58
ANGPTL3 Downregulation Increases Intracellular Lipids by Reducing Energy Utilization 57
Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats 57
Risk Alleles for Multiple Myeloma Susceptibility in ADME Genes 56
Genetic Biomarkers of Sorafenib Response in Patients with Hepatocellular Carcinoma 53
The Cytoscan HD Array in the Diagnosis of Neurodevelopmental Disorders 53
GENETIC SUSCEPTIBILITY TO GASTROINTESTINAL SYMPTOMS IN FABRY DISEASE 52
Integration of DNA Microarray with Clinical and Genomic Data 52
Mmrf-commpass data integration and analysis for identifying prognostic markers 51
Mirnas and lncrnas as novel therapeutic targets to improve cancer immunotherapy 51
Genetic variants associated with Fabry disease progression despite enzyme replacement therapy 51
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma 50
Exploring the impact of lipid droplets on the evolution and progress of hepatocarcinoma 50
Genetic variants associated with gastrointestinal symptoms in Fabry disease. 48
Ethical Perspectives on Pharmacogenomic Profiling 47
DMET™ (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine 47
From Single Level Analysis to Multi-Omics Integrative Approaches: A Powerful Strategy towards the Precision Oncology 46
The Effect of Physical Activity/Exercise on miRNA Expression and Function in Non-Communicable Diseases-A Systematic Review 46
null 43
Raman spectroscopic characterization of liver steatosis and fibrosis in a 2D and 3D in vitro thyroxine-treated hypothyroid cellular model 39
Genetic variants associated with Fabry disease progression despite enzyme replacement therapy. (IF 5.168) 39
Advances in Alport syndrome diagnosis using next-generation sequencing 37
Tools in Pharmacogenomics Biomarker Identification for Cancer Patients 36
The potential role of miRNAs in multiple myeloma therapy 34
null 31
GPER1 Activation Exerts Anti-Tumor Activity in Multiple Myeloma 30
TERRA G-quadruplex stabilization behind the anti-multiple myeloma activity: Novel insights about resveratrol pleiotropic effects 30
Functional Role of Linc-RNAs in Multiple Myeloma: Linc-MIR17HG Affects Fatty Acid Biosynthesis Via transcriptional Regulation of ACC1 with Potential Therapeutic Implications 28
High frequency of COH1 intragenic deletions and duplications detected by MLPA in patients with Cohen syndrome 25
Clinical Implementation of Sustainable Functional Foods and Nutraceuticals in Metabolic Health: A Feasibility Study 22
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma 13
Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92 12
Insulin plant (Costus igneus) extract alleviates steatosis and adiposity in a murine MASLD model by modulating hepatic lipogenesis and the CD9-CFD immunoregulatory axis 5
Totale 3.982
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.648
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.648
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022156 1 0 0 32 8 0 8 29 36 19 17 6
2022/2023453 75 31 22 19 59 40 7 33 60 33 49 25
2023/2024511 91 40 46 35 48 74 28 41 10 17 31 50
2024/2025976 92 33 33 50 62 126 73 60 56 23 156 212
2025/20261.764 130 173 147 191 168 95 250 91 195 168 104 52
Totale 3.982